Nuvalent Inc (NUVL)

10:05 AM

Nuvalent Inc. Stock Analysis and ForecastHigh-yield capital appreciation - Autocar Professional

10:05 AM

03:56 AM

What drives Nuvalent Inc. stock priceConsistent triple returns - Autocar Professional

03:56 AM

Jul 22, 2025

Is Nuvalent Inc. a good long term investmentHigh-impact stock picks - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Nuvalent Inc. stockUnprecedented profit potential - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Nuvalent Initiates Phase 3 ALKAZAR Trial of Neladalkib in NSCLC - Pharmacy Times

Jul 21, 2025

Jul 21, 2025

Nuvalent begins Phase 3 trial of neladalkib in ALK-positive lung cancer - Investing.com

Jul 21, 2025

Jul 21, 2025

Nuvalent Initiates Phase 3 ALKAZAR Clinical Trial - TipRanks

Jul 21, 2025

Jul 21, 2025

Nuvalent doses first patient in phase 3 lung cancer drug trial - Investing.com India

Jul 21, 2025

Jul 21, 2025

Nuvalent announces initiation of Alkazar phase 3 randomized - MarketScreener

Jul 21, 2025

Jul 21, 2025

Nuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLC - PR Newswire

Jul 21, 2025

Jul 18, 2025

How high can Nuvalent Inc. stock price go in 2025Profitable Yet Secure Picks - Newser

Jul 18, 2025

Jul 16, 2025

Nuvalent(NUVL) Shares Soar 3.01% on Positive Clinical Data - AInvest

Jul 16, 2025

Jul 16, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stock Position Decreased by Teacher Retirement System of Texas - Defense World

Jul 16, 2025

Jul 15, 2025

Why Nuvalent Inc. stock attracts strong analyst attentionDaily Trade Opportunity - Newser

Jul 15, 2025

Jul 15, 2025

How Nuvalent Inc. stock performs during market volatilityFree Capital Allocation Plans - Newser

Jul 15, 2025

Jul 15, 2025

What makes Nuvalent Inc. stock price move sharplyFree Access to Stock Community - Newser

Jul 15, 2025

Jul 15, 2025

Recent Analysts’ Ratings Updates for Nuvalent (NUVL) - Defense World

Jul 15, 2025

Jul 14, 2025

Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells $439,890.00 in Stock - Defense World

Jul 14, 2025

Jul 11, 2025

Nuvalent's Insider Sales and Clinical Milestones: A Balancing Act for Investors - AInvest

Jul 11, 2025

Jul 09, 2025

Nuvalent(NUVL) Shares Soar 3.47% on Positive Lung Cancer Data - AInvest

Jul 09, 2025

Jul 07, 2025

Nuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung Cancer - MSN

Jul 07, 2025

Jul 07, 2025

Nuvalent’s SWOT analysis: biotech stock’s pivotal year ahead By Investing.com - Investing.com Nigeria

Jul 07, 2025

Jul 07, 2025

Nuvalent’s SWOT analysis: biotech stock’s pivotal year ahead - Investing.com

Jul 07, 2025

Jul 06, 2025

10 Best High Short Interest Stocks With Huge Upside Potential - Insider Monkey

Jul 06, 2025

Jul 05, 2025

Nuvalent (NUVL) Gets a Buy from Goldman Sachs - The Globe and Mail

Jul 05, 2025

Jul 03, 2025

Nuvalent (NASDAQ:NUVL) Upgraded at The Goldman Sachs Group - Defense World

Jul 03, 2025

Jul 01, 2025

Goldman Sachs initiates coverage on Nuvalent stock with Buy rating By Investing.com - Investing.com India

Jul 01, 2025

Jun 30, 2025

Goldman Sachs initiates coverage on Nuvalent stock with Buy rating - Investing.com

Jun 30, 2025

Jun 27, 2025

Nuvalent chief development officer Noci sells $314k in shares - Investing.com

Jun 27, 2025

Jun 26, 2025

Barclays Sticks to Its Buy Rating for Nuvalent (NUVL) - The Globe and Mail

Jun 26, 2025